High responding factor VIII inhibitors in mild Haemophilia - is there a link with recent changes in clinical practice?
- 1 March 2000
- journal article
- case report
- Published by Wiley in Haemophilia
- Vol. 6 (2), 113-115
- https://doi.org/10.1046/j.1365-2516.2000.00390.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia ABlood, 1999
- Human recombinant DNA‐derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5‐year study of home therapyHaemophilia, 1999
- Factor VIII Inhibitors in Mild and Moderate-severity Haemophilia AThrombosis and Haemostasis, 1998
- A Multicenter Pharmacosurveillance Study for the Evaluation of the Efficacy and Safety of Recombinant Factor VIII in the Treatment of Patients with Hemophilia AThrombosis and Haemostasis, 1997
- Blood cytokine levels rise even after minor surgical traumaJournal of Clinical Immunology, 1996
- Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of InhibitorsNew England Journal of Medicine, 1993
- FACTOR VIII INHIBITOR IN MILD HAEMOPHILIABritish Journal of Haematology, 1986
- Factor VIII antibody in a patient with mild haemophiliaBritish Journal of Haematology, 1985